D'ADDATO, SERGIO
 Distribuzione geografica
Continente #
AS - Asia 7.824
EU - Europa 7.488
NA - Nord America 6.872
SA - Sud America 635
AF - Africa 361
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 23.195
Nazione #
US - Stati Uniti d'America 6.778
IT - Italia 3.317
CN - Cina 2.218
SG - Singapore 2.129
VN - Vietnam 1.865
GB - Regno Unito 1.283
DE - Germania 658
SE - Svezia 531
HK - Hong Kong 464
BR - Brasile 433
FR - Francia 380
IN - India 351
RU - Federazione Russa 278
KR - Corea 266
UA - Ucraina 242
NL - Olanda 188
IE - Irlanda 179
JP - Giappone 146
ZA - Sudafrica 123
CI - Costa d'Avorio 101
EE - Estonia 92
TG - Togo 81
AR - Argentina 76
FI - Finlandia 61
JO - Giordania 55
PL - Polonia 55
BD - Bangladesh 45
CA - Canada 45
CH - Svizzera 43
PE - Perù 41
IQ - Iraq 38
MX - Messico 38
ID - Indonesia 35
PH - Filippine 30
SA - Arabia Saudita 27
AT - Austria 26
ES - Italia 26
BG - Bulgaria 25
TR - Turchia 25
TH - Thailandia 24
GR - Grecia 23
EC - Ecuador 22
BE - Belgio 21
SC - Seychelles 18
CL - Cile 16
PK - Pakistan 16
VE - Venezuela 14
CO - Colombia 13
PY - Paraguay 13
TW - Taiwan 13
AU - Australia 10
AL - Albania 9
MY - Malesia 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 8
RO - Romania 8
TN - Tunisia 8
IR - Iran 7
LB - Libano 7
RS - Serbia 7
IL - Israele 6
NP - Nepal 6
CZ - Repubblica Ceca 5
HR - Croazia 5
LU - Lussemburgo 5
EU - Europa 4
KE - Kenya 4
LT - Lituania 4
LV - Lettonia 4
MA - Marocco 4
NG - Nigeria 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AZ - Azerbaigian 3
BY - Bielorussia 3
PS - Palestinian Territory 3
BO - Bolivia 2
CM - Camerun 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EG - Egitto 2
HN - Honduras 2
KZ - Kazakistan 2
QA - Qatar 2
TJ - Tagikistan 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
ET - Etiopia 1
GE - Georgia 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 23.180
Città #
Singapore 1.456
Southend 1.127
Hefei 634
Fairfield 587
Ashburn 564
Santa Clara 498
San Jose 473
Hong Kong 442
Chandler 416
Dong Ket 399
Ho Chi Minh City 371
Bologna 332
Hanoi 295
Wilmington 270
Woodbridge 270
Milan 265
Seattle 252
Houston 249
Princeton 244
Seoul 238
Beijing 231
Cambridge 213
Rome 197
Dublin 177
Ann Arbor 176
Boardman 176
Lauterbourg 154
Jacksonville 148
Tokyo 123
Turin 120
Nanjing 118
Los Angeles 117
Padova 115
Westminster 109
Abidjan 101
Berlin 83
Lomé 81
New York 75
Naples 74
Bremen 73
Buffalo 71
Dallas 70
Haiphong 56
Saint Petersburg 56
Council Bluffs 55
Amman 53
Bengaluru 53
Medford 52
São Paulo 52
Jinan 50
Shanghai 50
Helsinki 45
San Diego 45
Shenyang 42
Redondo Beach 41
Warsaw 40
Nanchang 39
Palermo 37
Lima 36
Hebei 35
The Dalles 34
Verona 34
Da Nang 33
Florence 33
Dearborn 32
Guangzhou 31
Parma 30
Changsha 29
Frankfurt am Main 29
Redwood City 28
London 27
Amsterdam 25
Chicago 25
Mülheim 25
Bari 24
Des Moines 24
Sofia 24
Zhengzhou 23
Modena 22
Nuremberg 22
Redmond 22
Bern 21
Hải Dương 21
Catania 19
Chengdu 19
Falls Church 19
Norwalk 19
Phoenix 19
Rimini 19
Biên Hòa 18
Can Tho 18
Hangzhou 18
Tianjin 18
Brussels 17
Munich 17
Ningbo 17
Torino 17
Baghdad 16
Genoa 16
Lanzhou 16
Totale 13.941
Nome #
Regressione completa di xantelasmi palpebrali in seguito a prolungatra terapia con statine: Case Report 1.718
Lo studio Brisighella: 40 anni di ricerca nella prevenzione delle malattie cardiovascolari. 1.187
Is the 2020 Sampson equation the best formula for LDL-C estimation? 275
A meta-analysis of Italian and Estonian individuals shows an effect of common variants in HMGCR on blood apoB levels 268
Effect of Dietary Supplementation with Eufortyn® Colesterolo Plus on Serum Lipids, Endothelial Reactivity, Indexes of Non-Alcoholic Fatty Liver Disease and Systemic Inflammation in Healthy Subjects with Polygenic Hypercholesterolemia: The ANEMONE Study. Nutrients. 2022 May 18;14(10):209 240
Wath are the major risk factors for type II diabetes development in the historical cohort of the Brisighella heart study? A 16-years follow-up 206
Relationship between lipid phenotypes, overweight, lipid lowering drug response and KIF6 and HMG-CoA genotypes in a subset of the brisighella heart study population 204
Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart Study 201
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 190
1A.11: ASSOCIATION OF KIF6 AND HMGCR LOCI WITH CARDIOMETABOLIC PHENOTYPES AND RESPONSE TO STATIN THERAPY IN THE BRISIGHELLA COHORT 187
Relazione tra livelli sierici di acido urico e rigidità arteriosa in un campione di adulti-anziani: i dati del Brisighella Heart Study 186
Epidemiologia della sindrome metabolica nel Brisighella heart study 183
A relative deficiency of lysosomal acid lypase activity characterizes non-alcoholic fatty liver disease 183
In vitro functional characterization of splicing variants of the APOB gene found in familial hypobetalipoproteinemia 183
Prevalence and the relative role of the main predictors of metabolic syndrome development in the hystorical cohort of the Brisighella heart study: 16-years follow-up 181
Enhancing stroke risk prediction in patients with transient ischemic attack: insights from a prospective cohort study implementing fast-track care 179
Effect of spontaneous changes in dietary components and lipoprotein(a) levels: Data from the Brisighella Heart Study 177
Arterial stiffness, sugar-sweetened beverages and fruits intake in a rural population sample: Data from the brisighella heart study 177
High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects 173
Self-Reported Coffee Consumption and Central and Peripheral Blood Pressure in the Cohort of the Brisighella Heart Study. 172
Relative role of major risk factors for Type 2 Diabetes development in the historical cohort of the Brisighella Heart Study: an 8-years follow-up. 171
Brisighella Heart Study: metabolic syndrome in a borderline area. 171
Prevalenza e determinati clinico-laboratoristici della sindrome metabolica in un campione di soggetti in età geriatrica: il Brisighella Heart Study 170
Prevalence of metabolic syndrome in working population: preliminary results fo a campaign of cardiovascular risk screening 170
Awareness of major cardiovascular risk factors and its relationship with markers of vascular aging: data from the Brisighella Heart Study 170
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 169
Serum uric acid change and modification of blood pressure and fasting plasma glucose in an overall healthy population sample: data from the Brisighella heart study 164
Efficacia della supplementazione dietetice con fibre solubili nelle gestione del rischio delle malattie cardiovascolari di pazienti affetti da SM: un trial clinico randomizzato open label di un anno 161
METABOLIC SYNDROME IN EUROPEAN RURAL POPULATION-DATA FROM THE BRISGHELLA HEART STUDY (ITALY) AND ENAH STUDY (CROATIA) 158
Cardiovascular mortality and physical activity in a rural population: the Brisighella Study. 158
Association between not HDL cholesterol levels and hypertension in the Brisighella Hart Study. 158
Farmaci ipocolesterolemizzanti. 157
Fatty liver index is associated to pulse wave velocity in healthy subjects: Data from the Brisighella Heart Study 156
Brisghella Heart Study (BHS): controllo dei valori pressori dal 1984 al 2004. 155
2B02: SERUM URIC ACID LEVEL, BUT NOT RENAL FUNCTION OR ARTERIAL STIFFNESS, IS ASSOCIATED TO WORSE BLOOD PRESSURE CONTROL IN GENERAL PRACTICE: DATA FROM THE BRISIGHELLA HEART STUDY 154
Correction to: Effect of a short-term dietary supplementation with phytosterols, red yeast rice or both on lipid pattern in moderately hypercholesterolemic subjects: A three-arm, double-blind, randomized clinical trial (Nutrition and Metabolism (2017) 14 (61) DOI: 10.1186/s12986-017-0214-2) 154
Serum lipoprotein(a) level as long-term predictor of cardiovascular mortality in a large sample of subjects in primary cardiovascular prevention: data from the Brisighella Heart Study 152
Iperlipoproteinemia familiare combinata: complicanze cardiovascolari e cerebrovascolari 151
Osservazioni clinico sperimentali su possibili relazioni tra andamento dei valori sierici di creatinina kinasi e colesterolo LDL in pazienti asintomatici con ipercoelsterolemia ed elevati livelli di CPK in corso di terapia con statine. 151
Three arms, double-blind, non-inferiority, randomized clinical study testing the lipid-lowering effect of a novel dietary supplement containing red yeast rice and artichoke extracts compared to Armolipid Plus® and placebo 150
A dietary education program involving the general population balances the effects of menopause on cardiovascular risk factors and metabolic syndrome incidence: data from the Brisghella Heart Study 150
Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study 148
Case Report: lipoproteina (A) is an indipendent risk factor for coronary artery disease: diagnosis and follow-up of a patient with high level of Lp(a) as only cardiovascular risk factor 148
Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene 147
Brisghella Heart Study (BHS): hypertension and obesity. 146
L'attività fisica durante il tempo libero e la mortalità per malattie cardiovascolari: i dati del Brisighella Heart Study. 145
Short- and Long-Term Stroke Risk after Urgent Management of Transient Ischaemic Attack: The Bologna TIA Clinical Pathway 144
Subjective effects of a combined lipid-lowering nutraceutical or ezetimibe on well-being and sexual performance in patients with perceived worsening of erectile function during statin treatment: a randomised clinical trial 144
Effect of a short-term dietary supplementation with phytosterols, red yeast rice or both on lipid pattern in moderately hypercholesterolemic subjects: A three-arm, double-blind, randomized clinical trial 143
Metabolic and vascular effect of a new standardized bergamot phytocomplex: a three-arm, placebocontrolled, double-blind clinical trial 141
Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q10 on lipid levels: A randomized, double-blind, placebo controlled study 140
Effect of a dietary education program on plasma lipid level in a rural setting: the Brisighella Heart Study 140
Coenzyne Q10 effect on the serum creatinine increase associated to rosuvastatin 20 mg in severe hypercholesterolemic patients 138
Physical activity and cardiovascular disease mortality: the Brisighella heart study 137
Attività fisica e aterosclerosi: i dati di Brisghella 137
Severe hypercholesterolaemia in a paediatric patient with congenital analbuminaemia 137
Relazione tra pressione arteriosa, colesterolemia ed apolipoproteina B in un campione di popolazione di grandi dimensioni: il Brisighella Heaat Study. 136
How important are triglycerides as risk factors? 136
Angiopoietin-like 3 and subclinical peripheral arterial disease: Evidence from the Brisighella Heart Study 136
Changes in levels of serum cholesterol and development of hypertension in the Brisighella Heart Study. 135
Hepatic steatosis index and lipid accumulation product as middle-term predictors of incident metabolic syndrome in a large population sample: data from the Brisighella Heart Study. 134
From risk factor assessment to cardiovascular disease risk and mortality modification: the first 40 years of the Brisighella Heart Study 134
Evaluation of twelve formulas for LDL-C estimation in a large, blinded, random Italian population. 134
LDL-oxidation, serum uric acid and pulse-wave velocity relationship in chronic kidney disease: Data from the Brisighella heart study cohort 133
Anlysis of lipid lowering treatment in patients at high cardiovascular risk discharged from S.Orsola-Malpighi Hospital, Bologna. 131
null 131
Confronto di due algoritmi diagnostici nella strima della prevalenza della sindrome metabolica in soggetti in età geriatrica e nella popolazione gnerale: Il Brisighella Heart Study. 130
Serum uric acid and markers of low-density lipoprotein oxidation in nonsmoking healthy subjects: data from the Brisighella Heart Study. 130
Observation of possibly relations between trend of CPK levels and LDL cholesterol in patients with hypercholesterolemia and asymptomatic primary high level of creatinechinase under statin therapy 130
Cardiovascular risk in patients with metabolic syndrome enrolled in the Brisighella Heart Study. 129
Healthy Eating beyond Whole Grains—Insight on Associations between Diet Quality and Arterial Stiffness in the Brisighella Heart Study Cohort 127
The Brisighella Heart Study: cardiovascular complications in subjects in subjects with metabolic syndrome. 125
Modification of the dietary habits in the Brisighella Heart Study 125
LDL-oxidation, serum uric acid, kidney function and pulse-wave velocity: Data from the Brisighella Heart Study cohort 124
Changes in levels of serum cholesterol and development of hypertension in the Brisighella Heart Study. 124
Circulating Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and Arterial Stiffness in a Large Population Sample: Data From the Brisighella Heart Study 124
Correction to: Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes (Cardiovascular Diabetology, (2022), 21, 1, (57), 10.1186/s12933-022-01495-8) 123
The Effect of Dietary Supplementation with Plant Sterols on Total and LDL-Cholesterol in Plasma Is Affected by Adherence to Mediterranean Diet: Insights from the DESCO Randomized Clinical Study 121
Relationship Between Serum Uric Acid and Electrocardiographic Alterations in a Large Sample of General Population: Data From the Brisighella Heart Study 121
Plasma lipid effects of corn oil and extra-virgin olive oil in hypercholesterolemic subjects: a randomized, controlled trial. 120
EFFECT OF SPONTANEOUS CHANGES IN DIETARY COMPONENTS AND SERUM LIPOPROTEIN(A): DATA FROM THE BRISIGHELLA HEART STUDY 119
Physical activity trend in a rural population submitted to a nutritional program: the Brisighella Heart Study 119
Additional therapy for cholesterol lowering in ezetimibe-treated, statin-intolerant patients in clinical practice: results from an internal audit of a university lipid clinic 119
Brisghella Heart Study (BHS): ipertensione ed obesità. 119
La compromissione della funzione renale in un campione di popolazione generale: dati del Brisighella Heart Study. 118
Main predictors of metabolic syndrome and type 2 diabetes development in the historical cohort of the Brisighella Heart Study: a 16 years follow-up. 118
Association between cigarette smoking and serum lipid levels in a italian cohort: the Brisighella Heart Study. 117
Laboratory and Instrumental Risk Factors Associated with a Sudden Cardiac Death Prone ECG Pattern in the General Population: Data from the Brisighella Heart Study 117
Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes 116
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 115
Prevalent seasoning and cooking fats, arterial stiffness and lipid pattern in a rural population sample: data from the Brisighella Heart Study 114
Long-Term Impact of Different Triple Combination Antihypertensive Medications on Blood Pressure Control, Metabolic Pattern and Incident Events: Data from the Brisighella Heart Study 114
Hypertension and metabolic syndrome in the Brisighella Heart Study 113
The relevance of soluble fibre dietary supplement in cardiovacular disease risk menagement of patients affected by metabolic syndrome (MS): a 1-year, open label, randomized clinical trial. 111
Circulating levels of PCSK9 and arterial stiffness in a large population sample: Data from the brisighella heart study 111
A Randomized, Double-Blinded, Placebo-Controlled, Clinical Study of the Effects of a Nutraceutical Combination (LEVELIP DUO ®) on LDL Cholesterol Levels and Lipid Pattern in Subjects with Sub-Optimal Blood Cholesterol Levels (NATCOL Study) 111
null 110
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 108
Hepatic steatosis index e lipid accumulation product come predittori dell'incidenza di sindrome metabolica nel medio termine in un ampio campione di popolazione: dati dal Brisighella Haert Study 108
CORRELATIONS BETWEEN SERUM THIOCYANATES AND HEART RISK FACTORS IN THE HISTORICAL BRISIGHELLA HEART STUDY COHORT 107
Totale 17.332
Categoria #
all - tutte 57.135
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.135


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021918 0 0 0 0 0 0 0 0 0 149 108 661
2021/20222.234 231 82 128 95 231 161 40 186 118 110 493 359
2022/20232.687 255 347 137 335 166 161 126 174 449 142 282 113
2023/20241.247 51 160 72 106 104 104 99 101 76 140 90 144
2024/20254.144 194 564 299 293 811 235 313 166 142 127 242 758
2025/20267.512 715 997 879 706 827 481 677 443 1.283 504 0 0
Totale 23.664